BioSpace News Archive

Ayala Pharmaceuticals, Inc., a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, primarily in genetically defined patient populations, announced that it will present at the H.C. Wainwright BioConnect Virtual Conference, taking place on January 10-13, 2022.

Vaxcyte, Inc. (Nasdaq: PCVX), announced today that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for VAX-24, its lead, 24-valent pneumococcal conjugate vaccine (PCV) candidate designed to prevent invasive pneumococcal disease.

Jnana Therapeutics will present a corporate overview at the 40th Annual J.P. Morgan Healthcare Conference on Thursday, January 13, 2022 at 10:30 a.m. ET.

Timber Pharmaceuticals, Inc. announced that John Koconis, Chairman and Chief Executive Officer, will present a corporate overview at the H.C. Wainwright BioConnect Virtual Conference being held on January 10-13, 2022.

Cidara Therapeutics, Inc. announced that the Compensation Committee of its Board of Directors granted non-qualified stock option awards and restricted stock units for an aggregate of 17,000 shares of its common stock to three new employees, pursuant to the Cidara Therapeutics, Inc. 2020 Inducement Incentive Plan, with a grant date of December 31, 2021.

Solid Biosciences Inc. today announced that Ilan Ganot, Chief Executive Officer, President and Co-Founder, will present at the 40th Annual J.P. Morgan Healthcare Conference on Thursday, January 13, 2022 at 9:00 am ET.

RareCyte Inc., (“RareCyte” or “The Company”) a leading provider of Precision Biology products and services recognized over 100% sales growth in their Services business in 2021.

RayzeBio, Inc. today announced that Ken Song, M.D., President and CEO of the Company, will be presenting at the 40th Annual J.P. Morgan Healthcare Conference being held virtually on Tuesday, January 11, 2022.

Bluestar Genomics, Inc. today announced that management will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on January 12 at 4:30 p.m. ET.

Rallybio Corporation today provided an update on recent accomplishments and announced expected upcoming milestones.